MIA MS Proj

gd1222
phamarceutical1.docx

Running head: ACELRX PHARMACEUTICALS INC 1

ACELRX PHARMACEUTICALS INC 2

Project plan proposal for acelrx pharmaceuticals Inc company

Student’s name:

Course number:

Institution:

Due date:

1.0 INTRODUCTION

AcelRX Pharmaceuticals Inc was founded on July 2005 by Thomas A. Schreck and Pamela P. Palmer. It is a specialty pharmaceutical company that participates in promoting and marketing inventive solutions for the treatment of mild to excruciating pain (“Innovative Therapies for Acute Pain,”2017). It is headquarter is located in Redwood City California. It is product is mainly comprised of DSUVIA and ZALVISO (Johnson, 2017). All the drugs manufactured in this company, are approved for sale and regulated by the food and drug administration and therefore, they can be distributed to clinics, retailers and hospitals. However, DSUVIA is yet to be approved till on 12th October 2017 (House, 2017).

1.1 The purpose of the organization

The existence of this company is to provide solutions to patients with arthritis, muscle injuries, pain after surgery and other serious injuries that may be a source of discomfort to the body. The company aims to set up a commercial website to link easily with retailers, stakeholders, the staff and the public and distribute their products at an affordable rate. The website will enhance transparency on the sales made.

1.2 Why company is of interest to me

I’m an expert in software development and medical practitioner and since the main objective of the proposed project is to develop software that will facilitate commercializing of innovative treatment methods that relief severe pain, then desire to solve that problem, attracted my interest.

2.0 A description of the project and it is relationship to the organization’s business objectives

This project will create ease of mobility such that the patient drugs will be delivered to the patients’ comfort of their homes. Reliable services and quality drugs are assured straight from the company to the retailers through personnel that are vetted by the board. The objective of the company is to develop software that will facilitate commercializing of innovative treatment methods that relief severe pain. Today, there is a rising need to make work easier by applying these developments owing to the advancements involving modern technology around the world. The software, whose performance is regulated, monitored and evaluated by the organization itself, serves as an online drugstore. This will help to enhance transparency with stakeholders. The general as administrators supervises every transaction made between the organizations.

The webpage will have a database where records of what has been sold from the warehouse and the current stock can be traced easily. The retailers’ database will comprise the drugs in stock at the warehouse and the delivery status of the drug they desire to buy. Their account will be set up by the organization after validation of legal documents is done. Purchases will made at a wholesale price from the company. The consumer will sets up his or her profile, and after verification, he or she will gain an access to the database. The consumer has to follow a protocol such as identity verification for their requirements to be processed to their specifications. This is to prevent drug users from exploiting the drugs for harmful purposes.

3.0 PROJECT SCOPE

The main purpose of AcelRelieverXP is to make easier of purchasing the prescribed pain medication for consumers and retailers, with confidence of receiving effective and quality medication, without overexploitation, and fraud.

3.1 project requirements

The project requires the producer and the retailer who are approved by the FDA and possess an equivalent licenses that is present in the software database. It is clear that, all retailers must have a Board of Pharmacy license and a certificate of completion from a recognized medical institution.

2.1.1 Deliverables

This project will require market strategies that are improved, will also require to focus on improved transparency, accredited recognition, consumer satisfaction, should ensure there is reduced or no delays, improved strategies to increase the market demand and increased participation of shareholders. Project will also require the affected parties such as shareholders, hospitals, clinics, the board of directors the FDA, the pharmacists and the general public.

2.2 Activities of the project

The project will start by setting up of the database in the organization and training of staff on how to use the database. After training the staff on how to use the database, there will be an identification of qualified retailers and appropriate training on how to use the retailers’ database. The second step will be the launch of the retailers’ database. The next step is to monitor the success of the launch to see whether retailers and the warehouses are easily adapting to the system to adopt it. The identified staff will need to correct any glitches that may occur in order to prepare them to the next move which will be a control test between the retailers and a selected population from the public. A control test is to confirm if the retailer-consumer system is functional. The final step, is the launching of the system to the general public so that they can access the database and begin making their orders

3.2 Schedule for project proposal

The project is expected to take duration of 18 months where the first 12 months would be used to put the system into effect between the company and the retailer. The remaining six months would be the duration used for the scheduled control test. After the period has elapsed, the organization now has the mandate to launch the program to the general public.

3.3 Breakdown structure

3.3.1 Organization data

In mid-June, AcelRelieverXP stock was trading in the mid of two range of U.S dollars, closing as low as $2.05, thus being highly undervalued (Orelli, 2017). After analysis the company's drug pipeline and the products offered were on a potentially high demand, outweighing the downside. The stock shares are expected to rise to over $10 U.S dollar, which amounts to 300% profit for shareholders.

3.3.2 implementing of hiring process

The process of hiring will start after setting up the database in a organization so that after setting up, the training of the staff start will follow to know how to use the database. The qualified retailer will be identified and suitable training on how to use retailers’ database will be provided. Once the retailers’ database is launched, the retailer will have to monitor the progress of the launched database to acclimatize himself or herself with the operations of a system as well as correcting any glitches that may rise. Once the retailer has adopted the system, there will be a control test between the retailer and selected population from the public to check if retailer-consumer system is functional.

3.3.3 Rolling out a new product or service

The company may opt to diagnose and treat conditions of all ages. We realize that there are many other factors that can affect health such as diet, environment, exercise and heredity. Therefore, rolling out a new product and services that can help to provide the most comprehensive Medicare, we can manage to optimize the care and well-being of the patient. Beside of a webpage, we can still have a combination of media advertising, networking and promotional events. Marketing and sales can be aggressively be done through creating our presence in the community and giving high school talk, doing volunteer work and much more.

3.4 Labor requirement

Everything will be done digitally meaning the number of workers will increase in the company. The software is only available in the United States of America so there will be no problem in development of software system

4.0 APPROVAL AND AUTHORITY TO PROCEED

We approve the project as described above, and authorize the team to proceed.

Name

Title

Date

Thomas A. Schreck

Chief executive officer

12th October 2017

Dr. Nathan Detroit

Project manager

12th 0ctober 2017

Stephen Park

FAD Director

12th October 2017

Approved By: Thomas Approved By: Nathan

Date: 12th October 2017 Date: 12th October

Conclusion

The existence of AcelRX Pharmaceuticals Inc Company is to provide solutions to patients with arthritis, muscle injuries, pain after surgery and other serious injuries that may be a source of discomfort to the body. This project will create ease of mobility such that patient drugs will be delivered at their comfort of their homes. The main purpose of AcelRelieverXP is to make easier of purchasing the prescribed pain medication for consumers and retailers without fear of medication error, fraud and overexploitation.

References

House, D. (2017). FDA action date tomorrow for AcelRx Pharma's pain med Dsuvia; shares up 1%. Retrieved 17th October 2017, from https://seekingalpha.com/news/3300459-fda-action-date-tomorrow-acelrx-pharmas-pain-med-dsuvia-shares-1-percent

Innovative Therapies for Acute Pain. (2017). Aclerx.com. Retrieved 17th October 2017, from http://www.acelrx.com/pipeline/index.php

Johnson, D. (2017). AcelRx Remains An Attractive Buy After Strong Run. Retrieved October 17th, 2017, from https://seekingalpha.com/article/4112682-acelrx-remains-attractive-buy-strong-run

Orelli, B. (2017). Why AcelRx Pharmaceuticals Inc Jumped Higher Today. The Motley Fool. Retrieved 17th October 2017, from https://www.fool.com/investing/2017/10/02/why-acelrx-pharmaceuticals-inc-jumped-higher-today.aspx